TickerFacts.

Mimedx Group, Inc. (MDXG): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$78.77M
Year ended 2025-12-31
2023-12-31: $40.54M2024-12-31: $64.91M2025-12-31: $78.77M$78.77M
2023-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$78.77M+21.4%2026-02-25, From 2025-01-01
2024-12-31$64.91M+60.1%2026-02-25, From 2024-01-01
2023-12-31$40.54Mn/a2026-02-25, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Mimedx Group, Inc. (MDXG)2025-12-31$78.77M+21.4%
Accuray Inc (ARAY)2026-06-30-$18.50Mn/m
Artivion, Inc. (AORT)2025-12-31$56.20M-10.9%
Glaukos Corp (GKOS)2025-12-31-$161.51Mn/m
Tactile Systems Technology Inc (TCMD)2025-12-31$35.92M+24.0%
Angiodynamics Inc (ANGO)2026-05-31-$16.97Mn/m
Bioventus Inc. (BVS)2025-12-31$100.99M+193.9%
PROCEPT BioRobotics Corp (PRCT)2025-12-31-$97.47Mn/m
UFP Technologies Inc (UFPT)2025-12-31$111.49M+16.6%

Compare MDXG, ARAY, AORT, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗